Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Am J Trop Med Hyg ; 106(2): 574-577, 2021 11 22.
Artigo em Inglês | MEDLINE | ID: mdl-34814109

RESUMO

Chaetomium sp. is a mold, member of the phylum Ascomycota. Clinical disease in humans is rare, particularly in children, for which only five cases have been reported. We report a 7-months-old female patient with a diagnosis of visceral heterotaxy syndrome who was admitted to a private center in Mexico. After two episodes of focal myoclonic seizure, a brain magnetic resonance imaging (MRI) revealed a right porencephalic cyst and a right frontal abscess with ventriculitis. Seventy-two hours after temporal abscesses drainage procedure, the culture showed a rapidly growing pale white fungal colony. Sequencing of internal transcribed spacer (ITS) and D1/D2 led to the identification of Chaetomium strumarium. Although Chaetomium sp. is a rare fungal infection in humans, clinicians should consider it as a plausible etiologic agent that can form brain abscess.


Assuntos
Feoifomicose Cerebral/diagnóstico por imagem , Chaetomium/patogenicidade , Síndrome de Heterotaxia/complicações , Micoses/diagnóstico por imagem , Antifúngicos/uso terapêutico , Encéfalo/diagnóstico por imagem , Chaetomium/genética , Feminino , Síndrome de Heterotaxia/microbiologia , Humanos , Lactente , Imageamento por Ressonância Magnética , México , Micoses/tratamento farmacológico
2.
Pediatrics ; 142(3)2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30068713

RESUMO

BACKGROUND: The capsular group B meningococcal vaccine (4CMenB) is recommended for children with complement deficiencies, asplenia, and splenic dysfunction; however, data on the immunogenicity of 4CMenB in these "at-risk" children are missing. METHODS: Participants aged 2 to 17 years in Italy, Spain, Poland, the United Kingdom, and Russia with complement deficiencies, asplenia, or splenic dysfunction received 2 doses of 4CMenB 2 months apart, as did healthy children in the control group. Exogenous and endogenous human complement serum bactericidal activity (SBA) was determined at baseline and 1 month after the second immunization against 4 test strains: H44/76 (assessing vaccine antigen factor H binding protein), 5/99 (Neisserial adhesion A), NZ98/254 (Porin A), and M10713 (Neisserial heparin binding antigen). RESULTS: Of 239 participants (mean age 10.3 years, 45% female), 40 children were complement deficient (9 eculizumab therapy, 4 terminal-chain deficiencies, 27 "other"), 112 children had asplenia or splenic dysfunction (8 congenital asplenia, 8 functional asplenia, 96 splenectomy), and 87 children were in the control group. After immunization, the proportions of complement-deficient participants with exogenous complement SBA titers ≥1:5 were 87% (H44/76), 95% (5/99), 68% (NZ98/254), and 73% (M10713), compared with 97%, 100%, 86%, and 94%, respectively, for asplenic children and 98%, 99%, 83%, and 99% for children in the control group. When testing with endogenous complement, strain-specific bactericidal activity was evident in only 1 eculizumab-treated participant and 1 terminal chain complement-deficient participant. CONCLUSIONS: 4CMenB administration is similarly immunogenic in healthy children and those with asplenia or splenic dysfunction. The significance of the trend to lower responses of SBA titers in complement-deficient children (especially those with terminal chain complement deficiency or those on eculizumab therapy) must be determined by ongoing surveillance for vaccine failures.


Assuntos
Proteínas do Sistema Complemento/deficiência , Imunogenicidade da Vacina/fisiologia , Infecções Meningocócicas/prevenção & controle , Vacinas Meningocócicas/uso terapêutico , Baço/fisiologia , Adolescente , Criança , Pré-Escolar , Proteínas do Sistema Complemento/fisiologia , Europa (Continente)/epidemiologia , Feminino , Síndrome de Heterotaxia/tratamento farmacológico , Síndrome de Heterotaxia/imunologia , Síndrome de Heterotaxia/microbiologia , Humanos , Masculino , Infecções Meningocócicas/epidemiologia , Infecções Meningocócicas/imunologia , Baço/efeitos dos fármacos , Baço/microbiologia
3.
BMC Infect Dis ; 17(1): 777, 2017 12 18.
Artigo em Inglês | MEDLINE | ID: mdl-29254492

RESUMO

BACKGROUND: Isolated congenital asplenia (ICA) is a rare and life-threatening condition that predisposes patients to severe bacterial infections. Most of the reported cases are familial and the mode of inheritance is usually autosomal dominant. Here, we report a case of sporadic isolated asplenia and review the literature while focusing on sporadic cases. CASE PRESENTATION: We report the case of an 11-month-old female infant who developed fulminant pneumococcal meningitis. The pneumococcal vaccine-unimmunized patient was hospitalized with fever, irritability, and purpura, and was diagnosed as having meningitis, septic shock, and disseminated intravascular coagulation. Streptococcus pneumoniae was isolated from both cerebrospinal fluid and blood. She was successfully treated with prompt antibiotic therapy. During hospitalization, abdominal ultrasonography and computed tomography findings, scintigraphy results, and Howell-Jolly body-containing red blood cells indicated the presence of asplenia without any visceroarterial anomalies. Moreover, the findings of peripheral blood smears and spleen ultrasonographic examinations of her parents were normal. CONCLUSIONS: Majority of sporadic ICA cases were detected only after the onset of overwhelming infection and had a high mortality. In cases of severe invasive pneumococcal disease, a systematic search for Howell-Jolly bodies on blood smears and the presence of asplenia on abdominal imaging are essential for detecting ICA even in the absence of any family history. After the diagnosis of ICA, patient and parent education, vaccinations, antibiotic prophylaxis, and prompt empiric treatment of febrile episode should be provided.


Assuntos
Síndrome de Heterotaxia/diagnóstico , Síndrome de Heterotaxia/microbiologia , Meningite Pneumocócica/diagnóstico , Streptococcus pneumoniae/isolamento & purificação , Feminino , Síndrome de Heterotaxia/tratamento farmacológico , Síndrome de Heterotaxia/patologia , Humanos , Lactente , Meningite Pneumocócica/tratamento farmacológico , Meningite Pneumocócica/microbiologia , Meningite Pneumocócica/patologia , Vacinas Pneumocócicas/administração & dosagem , Baço/anormalidades , Streptococcus pneumoniae/genética , Ultrassonografia , Vacinação
4.
Congenit Heart Dis ; 11(6): 537-547, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27425254

RESUMO

Heterotaxy (HTX) is a laterality defect resulting in abnormal arrangement of the thoracic and abdominal organs across the right-left axis, and is associated with multiple anatomic and physiologic disruptions. HTX often occurs in association with complex congenital heart disease. Splenic abnormalities are also common and convey an increased risk of bacteremia (bacteremia) with a high associated mortality. We performed a systematic review of the literature studying the risk of infection in HTX patients and strategies that can be utilized to prevent such infections. Studies were identified for inclusion using PubMed, EMBASE, and OVID, as well as hand search of references from previously identified papers. Published studies specifically investigating bacteremia in HTX were identified and included as long as they were in English. Data were extracted by two separate authors independently with review of any findings that differed between the two authors. There were 42 documented cases of bacteremia in 32 patients. Approximately, 79% of these had absence of a spleen. The average age of bacteremia was 17 months. HTX patients are at high risk for bacteremia leading to mortality, regardless of anatomic splenic type. We propose strategies for the evaluation of splenic function in HTX patients, and review management practices to reduce the impact of infection risk in the HTX population.


Assuntos
Bacteriemia/terapia , Infecções Bacterianas/terapia , Síndrome de Heterotaxia/terapia , Baço/anormalidades , Bacteriemia/diagnóstico , Bacteriemia/microbiologia , Bacteriemia/mortalidade , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/microbiologia , Infecções Bacterianas/mortalidade , Síndrome de Heterotaxia/diagnóstico , Síndrome de Heterotaxia/microbiologia , Síndrome de Heterotaxia/mortalidade , Humanos , Incidência , Lactente , Recém-Nascido , Prognóstico , Fatores de Risco
5.
Pediatr Infect Dis J ; 33(6): 661-4, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24463808

RESUMO

The second case of Bordetella holmesii endocarditis in a pediatric patient is presented. This patient had a prosthetic mitral valve and asplenia. He was successfully treated with 6 weeks of intravenous meropenem. We review all 9 other reported cases of endocarditis and summarize treatment and outcome. Five were immunocompromised and 6 had predisposing cardiac conditions.


Assuntos
Infecções por Bordetella/microbiologia , Bordetella/isolamento & purificação , Endocardite Bacteriana/microbiologia , Criança , Síndrome de Heterotaxia/microbiologia , Humanos , Hospedeiro Imunocomprometido , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA